Supplement filed pursuant to Rule 253(g)(2)
File No. 024-11229
SUPPLEMENT DATED AUGUST 31, 2021
TO OFFERING CIRCULAR DATED AUGUST 25, 2020
FISHER WALLACE LABORATORIES, INC.
EXPLANATORY NOTE
This document supplements, and should be read in conjunction with, the Offering Circular dated August 25, 2020 (the “Offering Circular”) of Fisher Wallace Laboratories, Inc. (the “Company”), as amended and supplemented. The Offering Circular is Here. Unless otherwise defined in this supplement, capitalized terms used in this supplement shall have the same meanings as set forth in the Offering Circular.
The purpose of this supplement is to announce the Company’s intention to terminate the offering described in the Offering Circular, on October 26, 2021, as qualified by reference to the description of the Company’s intentions below.
Offering Termination Date
The Company intends to terminate the offering for its Class A Common Stock described in the Offering Circular. No further subscriptions will be accepted for the current offering after October 26, 2021 (the “Termination Date”). Subscriptions in the offering will be accepted up to that date and processed as promptly as possible. None of the terms of the offering have been changed. In addition, as described in the Offering Circular, the Company retains the right to continue the offering beyond the Termination Date, in its sole discretion.